Comparative Efficacy Of Intraductal Antibiotic During ERCP In Acute Cholangitis
Recruiting
Phase 2
Interventional Study
Acute Cholangitis
Biliary Tract Infection
Biliary Obstruction
Choledocholithiasis
Malignant Biliary Stricture
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 172 (estimated)
- Sponsor
- National University of Malaysia · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Does intraductal administration of antibiotics during endoscopic retrograde cholangiopancreatography (ERCP), in addition to standard systemic antibiotic therapy, improve clinical outcomes in patients with acute cholangitis compared with standard systemic antibiotic therapy alone?
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The patients diagnosed with mild and moderate acute cholangitis based on TG 18
* Planned for ERCP within 48 hours
* 18 years old and above
Exclusion Criteria:
* Severe acute cholangitis
* History of antibiotic hypersensitivity
* Receiving cancer chemotherapy, steroids, or im…
Contacts